Humanwell Healthcare (SHA:600079) agreed to place shares worth between 3 billion yuan and 3.50 billion yuan to its controlling shareholder, CMB Life Science Technology (Wuhan), according to a Shanghai bourse filing on Wednesday.
The pharmaceutical company will place between around 200.7 million and 234.1 million shares for 14.95 yuan apiece.
The company's shares jumped less than 3% during the afternoon trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments